Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Antiemetic Drugs Market Growth 2022-2028

  • LP 4809200
  • 113 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Antiemetic Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Antiemetic Drugs market size is USD million in 2022 from USD 4652.2 million in 2021, with a change of % between 2021 and 2022. The global Antiemetic Drugs market size will reach USD 6384.9 million in 2028, growing at a CAGR of 4.6% over the analysis period.

The United States Antiemetic Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antiemetic Drugs market, reaching US$ million by the year 2028. As for the Europe Antiemetic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Antiemetic Drugs players cover GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Antiemetic Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Dopamine Antagonist

5-HT-3 Receptor Antagonist

NK1 Receptor Antagonist

Cannabinoid Receptor Antagonist

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Chemotherapy

Gastroenteritis

Surgery

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GlaxoSmithKline

Johnson & Johnson

Pfizer

Sanofi

Abbott

Bristol-Myers Squibb

Cipla

Eisai

Eli Lilly

Glenmark

Helsinn Healthcare

Heron Therapeutics

IPCA Laboratories

Lupin

Merck

Novartis

RedHill

Sun Pharmaceutical Industries

Takeda Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antiemetic Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antiemetic Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antiemetic Drugs by Country/Region, 2017, 2022 & 2028

2.2 Antiemetic Drugs Segment by Type

2.2.1 Dopamine Antagonist

2.2.2 5-HT-3 Receptor Antagonist

2.2.3 NK1 Receptor Antagonist

2.2.4 Cannabinoid Receptor Antagonist

2.3 Antiemetic Drugs Sales by Type

2.3.1 Global Antiemetic Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Antiemetic Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antiemetic Drugs Sale Price by Type (2017-2022)

2.4 Antiemetic Drugs Segment by Application

2.4.1 Chemotherapy

2.4.2 Gastroenteritis

2.4.3 Surgery

2.5 Antiemetic Drugs Sales by Application

2.5.1 Global Antiemetic Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Antiemetic Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antiemetic Drugs Sale Price by Application (2017-2022)

3 Global Antiemetic Drugs by Company

3.1 Global Antiemetic Drugs Breakdown Data by Company

3.1.1 Global Antiemetic Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Antiemetic Drugs Sales Market Share by Company (2020-2022)

3.2 Global Antiemetic Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Antiemetic Drugs Revenue by Company (2020-2022)

3.2.2 Global Antiemetic Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Antiemetic Drugs Sale Price by Company

3.4 Key Manufacturers Antiemetic Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antiemetic Drugs Product Location Distribution

3.4.2 Players Antiemetic Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antiemetic Drugs by Geographic Region

4.1 World Historic Antiemetic Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Antiemetic Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antiemetic Drugs Annual Revenue by Geographic Region

4.2 World Historic Antiemetic Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Antiemetic Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antiemetic Drugs Annual Revenue by Country/Region

4.3 Americas Antiemetic Drugs Sales Growth

4.4 APAC Antiemetic Drugs Sales Growth

4.5 Europe Antiemetic Drugs Sales Growth

4.6 Middle East & Africa Antiemetic Drugs Sales Growth

5 Americas

5.1 Americas Antiemetic Drugs Sales by Country

5.1.1 Americas Antiemetic Drugs Sales by Country (2017-2022)

5.1.2 Americas Antiemetic Drugs Revenue by Country (2017-2022)

5.2 Americas Antiemetic Drugs Sales by Type

5.3 Americas Antiemetic Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antiemetic Drugs Sales by Region

6.1.1 APAC Antiemetic Drugs Sales by Region (2017-2022)

6.1.2 APAC Antiemetic Drugs Revenue by Region (2017-2022)

6.2 APAC Antiemetic Drugs Sales by Type

6.3 APAC Antiemetic Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antiemetic Drugs by Country

7.1.1 Europe Antiemetic Drugs Sales by Country (2017-2022)

7.1.2 Europe Antiemetic Drugs Revenue by Country (2017-2022)

7.2 Europe Antiemetic Drugs Sales by Type

7.3 Europe Antiemetic Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antiemetic Drugs by Country

8.1.1 Middle East & Africa Antiemetic Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antiemetic Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Antiemetic Drugs Sales by Type

8.3 Middle East & Africa Antiemetic Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antiemetic Drugs

10.3 Manufacturing Process Analysis of Antiemetic Drugs

10.4 Industry Chain Structure of Antiemetic Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antiemetic Drugs Distributors

11.3 Antiemetic Drugs Customer

12 World Forecast Review for Antiemetic Drugs by Geographic Region

12.1 Global Antiemetic Drugs Market Size Forecast by Region

12.1.1 Global Antiemetic Drugs Forecast by Region (2023-2028)

12.1.2 Global Antiemetic Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antiemetic Drugs Forecast by Type

12.7 Global Antiemetic Drugs Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline Antiemetic Drugs Product Offered

13.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Company Information

13.2.2 Johnson & Johnson Antiemetic Drugs Product Offered

13.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson & Johnson Main Business Overview

13.2.5 Johnson & Johnson Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Antiemetic Drugs Product Offered

13.3.3 Pfizer Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Sanofi

13.4.1 Sanofi Company Information

13.4.2 Sanofi Antiemetic Drugs Product Offered

13.4.3 Sanofi Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sanofi Main Business Overview

13.4.5 Sanofi Latest Developments

13.5 Abbott

13.5.1 Abbott Company Information

13.5.2 Abbott Antiemetic Drugs Product Offered

13.5.3 Abbott Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abbott Main Business Overview

13.5.5 Abbott Latest Developments

13.6 Bristol-Myers Squibb

13.6.1 Bristol-Myers Squibb Company Information

13.6.2 Bristol-Myers Squibb Antiemetic Drugs Product Offered

13.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bristol-Myers Squibb Main Business Overview

13.6.5 Bristol-Myers Squibb Latest Developments

13.7 Cipla

13.7.1 Cipla Company Information

13.7.2 Cipla Antiemetic Drugs Product Offered

13.7.3 Cipla Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cipla Main Business Overview

13.7.5 Cipla Latest Developments

13.8 Eisai

13.8.1 Eisai Company Information

13.8.2 Eisai Antiemetic Drugs Product Offered

13.8.3 Eisai Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eisai Main Business Overview

13.8.5 Eisai Latest Developments

13.9 Eli Lilly

13.9.1 Eli Lilly Company Information

13.9.2 Eli Lilly Antiemetic Drugs Product Offered

13.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly Main Business Overview

13.9.5 Eli Lilly Latest Developments

13.10 Glenmark

13.10.1 Glenmark Company Information

13.10.2 Glenmark Antiemetic Drugs Product Offered

13.10.3 Glenmark Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Glenmark Main Business Overview

13.10.5 Glenmark Latest Developments

13.11 Helsinn Healthcare

13.11.1 Helsinn Healthcare Company Information

13.11.2 Helsinn Healthcare Antiemetic Drugs Product Offered

13.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Helsinn Healthcare Main Business Overview

13.11.5 Helsinn Healthcare Latest Developments

13.12 Heron Therapeutics

13.12.1 Heron Therapeutics Company Information

13.12.2 Heron Therapeutics Antiemetic Drugs Product Offered

13.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Heron Therapeutics Main Business Overview

13.12.5 Heron Therapeutics Latest Developments

13.13 IPCA Laboratories

13.13.1 IPCA Laboratories Company Information

13.13.2 IPCA Laboratories Antiemetic Drugs Product Offered

13.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 IPCA Laboratories Main Business Overview

13.13.5 IPCA Laboratories Latest Developments

13.14 Lupin

13.14.1 Lupin Company Information

13.14.2 Lupin Antiemetic Drugs Product Offered

13.14.3 Lupin Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Lupin Main Business Overview

13.14.5 Lupin Latest Developments

13.15 Merck

13.15.1 Merck Company Information

13.15.2 Merck Antiemetic Drugs Product Offered

13.15.3 Merck Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Merck Main Business Overview

13.15.5 Merck Latest Developments

13.16 Novartis

13.16.1 Novartis Company Information

13.16.2 Novartis Antiemetic Drugs Product Offered

13.16.3 Novartis Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Novartis Main Business Overview

13.16.5 Novartis Latest Developments

13.17 RedHill

13.17.1 RedHill Company Information

13.17.2 RedHill Antiemetic Drugs Product Offered

13.17.3 RedHill Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 RedHill Main Business Overview

13.17.5 RedHill Latest Developments

13.18 Sun Pharmaceutical Industries

13.18.1 Sun Pharmaceutical Industries Company Information

13.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Product Offered

13.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Sun Pharmaceutical Industries Main Business Overview

13.18.5 Sun Pharmaceutical Industries Latest Developments

13.19 Takeda Pharmaceutical

13.19.1 Takeda Pharmaceutical Company Information

13.19.2 Takeda Pharmaceutical Antiemetic Drugs Product Offered

13.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Takeda Pharmaceutical Main Business Overview

13.19.5 Takeda Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Antiemetic Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antiemetic Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Dopamine Antagonist

Table 4. Major Players of 5-HT-3 Receptor Antagonist

Table 5. Major Players of NK1 Receptor Antagonist

Table 6. Major Players of Cannabinoid Receptor Antagonist

Table 7. Global Antiemetic Drugs Sales by Type (2017-2022) & (K Units)

Table 8. Global Antiemetic Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Antiemetic Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Antiemetic Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Antiemetic Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Antiemetic Drugs Sales by Application (2017-2022) & (K Units)

Table 13. Global Antiemetic Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Antiemetic Drugs Revenue by Application (2017-2022)

Table 15. Global Antiemetic Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Antiemetic Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Antiemetic Drugs Sales by Company (2020-2022) & (K Units)

Table 18. Global Antiemetic Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Antiemetic Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Antiemetic Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Antiemetic Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Antiemetic Drugs Producing Area Distribution and Sales Area

Table 23. Players Antiemetic Drugs Products Offered

Table 24. Antiemetic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Antiemetic Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Antiemetic Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Antiemetic Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Antiemetic Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Antiemetic Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Antiemetic Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Antiemetic Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Antiemetic Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Antiemetic Drugs Sales by Country (2017-2022) & (K Units)

Table 36. Americas Antiemetic Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Antiemetic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Antiemetic Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Antiemetic Drugs Sales by Type (2017-2022) & (K Units)

Table 40. Americas Antiemetic Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Antiemetic Drugs Sales by Application (2017-2022) & (K Units)

Table 42. Americas Antiemetic Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Antiemetic Drugs Sales by Region (2017-2022) & (K Units)

Table 44. APAC Antiemetic Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Antiemetic Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Antiemetic Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Antiemetic Drugs Sales by Type (2017-2022) & (K Units)

Table 48. APAC Antiemetic Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Antiemetic Drugs Sales by Application (2017-2022) & (K Units)

Table 50. APAC Antiemetic Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Antiemetic Drugs Sales by Country (2017-2022) & (K Units)

Table 52. Europe Antiemetic Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Antiemetic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Antiemetic Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Antiemetic Drugs Sales by Type (2017-2022) & (K Units)

Table 56. Europe Antiemetic Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Antiemetic Drugs Sales by Application (2017-2022) & (K Units)

Table 58. Europe Antiemetic Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Antiemetic Drugs Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Antiemetic Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Antiemetic Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Antiemetic Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Antiemetic Drugs Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Antiemetic Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Antiemetic Drugs Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Antiemetic Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Antiemetic Drugs

Table 68. Key Market Challenges & Risks of Antiemetic Drugs

Table 69. Key Industry Trends of Antiemetic Drugs

Table 70. Antiemetic Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Antiemetic Drugs Distributors List

Table 73. Antiemetic Drugs Customer List

Table 74. Global Antiemetic Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Antiemetic Drugs Sales Market Forecast by Region

Table 76. Global Antiemetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Antiemetic Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Antiemetic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Antiemetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Antiemetic Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Antiemetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Antiemetic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Antiemetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Antiemetic Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Antiemetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Antiemetic Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Antiemetic Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Antiemetic Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Antiemetic Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Antiemetic Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Antiemetic Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Antiemetic Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Antiemetic Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. GlaxoSmithKline Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. GlaxoSmithKline Antiemetic Drugs Product Offered

Table 96. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. GlaxoSmithKline Main Business

Table 98. GlaxoSmithKline Latest Developments

Table 99. Johnson & Johnson Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Johnson & Johnson Antiemetic Drugs Product Offered

Table 101. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Johnson & Johnson Main Business

Table 103. Johnson & Johnson Latest Developments

Table 104. Pfizer Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Pfizer Antiemetic Drugs Product Offered

Table 106. Pfizer Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Pfizer Main Business

Table 108. Pfizer Latest Developments

Table 109. Sanofi Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Sanofi Antiemetic Drugs Product Offered

Table 111. Sanofi Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Sanofi Main Business

Table 113. Sanofi Latest Developments

Table 114. Abbott Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Abbott Antiemetic Drugs Product Offered

Table 116. Abbott Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Abbott Main Business

Table 118. Abbott Latest Developments

Table 119. Bristol-Myers Squibb Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Bristol-Myers Squibb Antiemetic Drugs Product Offered

Table 121. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Bristol-Myers Squibb Main Business

Table 123. Bristol-Myers Squibb Latest Developments

Table 124. Cipla Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Cipla Antiemetic Drugs Product Offered

Table 126. Cipla Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Cipla Main Business

Table 128. Cipla Latest Developments

Table 129. Eisai Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Eisai Antiemetic Drugs Product Offered

Table 131. Eisai Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Eisai Main Business

Table 133. Eisai Latest Developments

Table 134. Eli Lilly Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Eli Lilly Antiemetic Drugs Product Offered

Table 136. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Eli Lilly Main Business

Table 138. Eli Lilly Latest Developments

Table 139. Glenmark Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Glenmark Antiemetic Drugs Product Offered

Table 141. Glenmark Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Glenmark Main Business

Table 143. Glenmark Latest Developments

Table 144. Helsinn Healthcare Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Helsinn Healthcare Antiemetic Drugs Product Offered

Table 146. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Helsinn Healthcare Main Business

Table 148. Helsinn Healthcare Latest Developments

Table 149. Heron Therapeutics Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Heron Therapeutics Antiemetic Drugs Product Offered

Table 151. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Heron Therapeutics Main Business

Table 153. Heron Therapeutics Latest Developments

Table 154. IPCA Laboratories Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. IPCA Laboratories Antiemetic Drugs Product Offered

Table 156. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. IPCA Laboratories Main Business

Table 158. IPCA Laboratories Latest Developments

Table 159. Lupin Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Lupin Antiemetic Drugs Product Offered

Table 161. Lupin Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 162. Lupin Main Business

Table 163. Lupin Latest Developments

Table 164. Merck Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Merck Antiemetic Drugs Product Offered

Table 166. Merck Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 167. Merck Main Business

Table 168. Merck Latest Developments

Table 169. Novartis Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Novartis Antiemetic Drugs Product Offered

Table 171. Novartis Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 172. Novartis Main Business

Table 173. Novartis Latest Developments

Table 174. RedHill Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 175. RedHill Antiemetic Drugs Product Offered

Table 176. RedHill Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 177. RedHill Main Business

Table 178. RedHill Latest Developments

Table 179. Sun Pharmaceutical Industries Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 180. Sun Pharmaceutical Industries Antiemetic Drugs Product Offered

Table 181. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 182. Sun Pharmaceutical Industries Main Business

Table 183. Sun Pharmaceutical Industries Latest Developments

Table 184. Takeda Pharmaceutical Basic Information, Antiemetic Drugs Manufacturing Base, Sales Area and Its Competitors

Table 185. Takeda Pharmaceutical Antiemetic Drugs Product Offered

Table 186. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 187. Takeda Pharmaceutical Main Business

Table 188. Takeda Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Antiemetic Drugs

Figure 2. Antiemetic Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antiemetic Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Antiemetic Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antiemetic Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Dopamine Antagonist

Figure 10. Product Picture of 5-HT-3 Receptor Antagonist

Figure 11. Product Picture of NK1 Receptor Antagonist

Figure 12. Product Picture of Cannabinoid Receptor Antagonist

Figure 13. Global Antiemetic Drugs Sales Market Share by Type in 2021

Figure 14. Global Antiemetic Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Antiemetic Drugs Consumed in Chemotherapy

Figure 16. Global Antiemetic Drugs Market: Chemotherapy (2017-2022) & (K Units)

Figure 17. Antiemetic Drugs Consumed in Gastroenteritis

Figure 18. Global Antiemetic Drugs Market: Gastroenteritis (2017-2022) & (K Units)

Figure 19. Antiemetic Drugs Consumed in Surgery

Figure 20. Global Antiemetic Drugs Market: Surgery (2017-2022) & (K Units)

Figure 21. Global Antiemetic Drugs Sales Market Share by Application (2017-2022)

Figure 22. Global Antiemetic Drugs Revenue Market Share by Application in 2021

Figure 23. Antiemetic Drugs Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Antiemetic Drugs Revenue Market Share by Company in 2021

Figure 25. Global Antiemetic Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Antiemetic Drugs Revenue Market Share by Geographic Region in 2021

Figure 27. Global Antiemetic Drugs Sales Market Share by Region (2017-2022)

Figure 28. Global Antiemetic Drugs Revenue Market Share by Country/Region in 2021

Figure 29. Americas Antiemetic Drugs Sales 2017-2022 (K Units)

Figure 30. Americas Antiemetic Drugs Revenue 2017-2022 ($ Millions)

Figure 31. APAC Antiemetic Drugs Sales 2017-2022 (K Units)

Figure 32. APAC Antiemetic Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Europe Antiemetic Drugs Sales 2017-2022 (K Units)

Figure 34. Europe Antiemetic Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Antiemetic Drugs Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Antiemetic Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Americas Antiemetic Drugs Sales Market Share by Country in 2021

Figure 38. Americas Antiemetic Drugs Revenue Market Share by Country in 2021

Figure 39. United States Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Antiemetic Drugs Sales Market Share by Region in 2021

Figure 44. APAC Antiemetic Drugs Revenue Market Share by Regions in 2021

Figure 45. China Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Antiemetic Drugs Sales Market Share by Country in 2021

Figure 52. Europe Antiemetic Drugs Revenue Market Share by Country in 2021

Figure 53. Germany Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Antiemetic Drugs Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Antiemetic Drugs Revenue Market Share by Country in 2021

Figure 60. Egypt Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Antiemetic Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Antiemetic Drugs in 2021

Figure 66. Manufacturing Process Analysis of Antiemetic Drugs

Figure 67. Industry Chain Structure of Antiemetic Drugs

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390